ArticleFrontiers in oncology2020
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer.
Abstract read
In one paragraph
Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.BMC cancer · 2021Trial
- Feasibility of surface-guided radiotherapy for detecting patient instability during prostate radiotherapy.Radiation oncology journal · 2026Article
- The Kilovoltage Intrafraction Monitoring Real-Time Prostate Cancer Image Guided Radiation Therapy Technology Journey: From Clinical Trials to Your Clinic.International journal of radiation oncology, biology, physics · 2026Article
- Impact of intra- and interfractional motion on the dose distribution and urinary adverse events for magnetic resonance-guided prostate cancer radiotherapy.Physics and imaging in radiation oncology · 2026Article
- Magnetic Resonance Guided Radiation Therapy (MRgRT) Prostate Motion and Margins.Journal of medical radiation sciences · 2026Article
- Impact of intrafraction fiducial tracking on planning target margins during prostate stereotactic body radiotherapy using Brainlab ExacTrac Dynamic with robotic couch correction.Journal of applied clinical medical physics · 2025Article
- Evaluation of knowledge-based planning models for male pelvic CBCT-based online adaptive radiotherapy on conventional linear accelerators.Journal of applied clinical medical physics · 2024Article
- Stereotactic body radiation therapy (SBRT) for prostate cancer: Improving treatment delivery efficiency and accuracy.Technical innovations & patient support in radiation oncology · 2024Article
- Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion.Current oncology (Toronto, Ont.) · 2024Article
- Impact of technological advances in treatment planning, image guidance, and treatment delivery on target margin design for prostate cancer radiotherapy: an updated review.The British journal of radiology · 2024Review
- Dynamic intrafractional position monitoring with implanted fiducial markers for enhanced accuracy in radiotherapy of prostate cancer.Physical and engineering sciences in medicine · 2023Article
- Prostate stereotactic body radiotherapy: quantifying intra-fraction motion and calculating margins using the new BIR geometric uncertainties in daily online IGRT recommendations.The British journal of radiology · 2023Article
- Reducing PTV margins for prostate SBRT with motion compensation and gating techniques.Journal of applied clinical medical physics · 2023Article
- Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.JAMA oncology · 2023Article
- Optimal planning target margin for prostate radiotherapy based on interfractional and intrafractional variability assessment during 1.5T MRI-guided radiotherapy.Frontiers in oncology · 2023Article
- Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac.Technical innovations & patient support in radiation oncology · 2022Article
- Retrospective analysis of MV-kV imaging-based fiducial tracking in prostate SBRT treatment.Journal of applied clinical medical physics · 2022Article
- Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.Radiation oncology (London, England) · 2022Article
- Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy.Frontiers in oncology · 2022Article
- MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer.Cancers · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Rebecca Levin-EpsteinDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
George Qiao-GuanCase Western Reserve School of Medicine, Cleveland, OH, United States.
Jesus E JuarezDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Zhouhuizi ShenDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Michael L SteinbergDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Dan RuanDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Luca ValleDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Nicholas G NickolsDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Patrick A KupelianDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Christopher R KingDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Minsong CaoDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Amar U KishanDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, United States.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
image-guidancemarginsplanning target volumeprostate cancerprostate motionSBRTstereotactic body radiation therapy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.